Skip to main content
Clinical Trials/DRKS00007786
DRKS00007786Completed未知

Clinical study on the effectiveness of three products in the treatment of herpes simplex labialis

Sylphar NV0 sites180 target enrollmentStarted: June 16, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
180

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 65 Years (—)
Sex
All

Inclusion Criteria

  • Male and female patients in the age of 18 till 65 years
  • Written approval of the participant person after clarification
  • Healthy probands, Probands with a finished therapy, without a hurtful tooth or mucosa illness
  • Acute Herpes Simplex labialis

Exclusion Criteria

  • Signs that the patient is unable to comply with the test plan (eg lack of cooperation)
  • Probands with severe general medical disorders
  • The taking of antibiotic or antiphlogistic drugs in the last two weeks prior to study entry
  • The taking of anti-inflammatory drugs during the study period
  • oral diseases, for example Ulcerative gingivitis (NUG), periodontitis colitis (NUP)
  • Immune systeme disorders
  • Known hypersensitivity to the substances used in the study
  • Pregnangcy or lactation
  • Alcohol or drug abuse in the recent past or last year
  • An employee of the sponsor or the study, or a member of their close Family
  • Participation in another clinical study or taking a to examined drug within the 30 days oft he test phase

Investigators

Sponsor
Sylphar NV

Similar Trials

Clinical study on the effectiveness of... | Clinical Trial